NASDAQ
CymaBay Therapeutics, Inc. (CBAY) has a revenue compound annual growth rate of 25.45% over 5 years and 26.13% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.